Articles tagged with Cell Growth
Scientists discovered that beta-interferon inhibits tumor growth by blocking its connection to the blood circulatory system and reducing the production of growth factors. This effect was seen in mice where tumors grew slower and formed fewer metastases, highlighting a new potential target for cancer therapy.
A Rice University researcher has developed a natural extracellular matrix from adipose cells that supports the growth of living cells into tissues. The substance, called Adipogel, has been proven effective for growing liver cells and may be used to repair damaged organs in the future.
Rival bacterial colonies use a toxic protein called sibling lethal factor to outcompete each other for limited nutrients. The protein kills cells at the edge of a colony closest to a competing group, creating a lopsided growth pattern and preserving scarce resources.
Researchers at Tel Aviv University are developing a new retinal implant technology that can stimulate cell growth in the retina, potentially leading to improved vision. The technology uses electrodes to merge retinal nerves with nano-sized carbon tubes, allowing for the growth of living neurons on a synthetic structure.
A study published in Immunity reveals that immune cells' signals can interfere with the ability of intestinal cells to regenerate, leading to hyper-activation of growth and increasing the risk of colon cancer. Interfering with a protein called dickkopf 1 may aid in controlling inflammatory bowel diseases.
Researchers identified a new drug target to inhibit genes vital for leukaemia cell growth, which could prevent disease progression. Targeting Stat5 may provide a novel therapeutic approach for treating acute and chronic leukaemias.
The study found that maternal high blood pressure, high hematocrit levels, and smoking are associated with restricted fetal growth during the first trimester. This restriction is linked to an increased risk of preterm birth, low birth weight, and small size for gestational age at birth.
Researchers enhanced a type of cellular senescence to suppress prostate tumor development and growth in mice. This novel approach uses Pten-loss-induced cellular senescence to prevent cancer progression.
Women with IUGR may experience similar adverse neonatal outcomes when waiting for birth versus induced labor, according to a randomized controlled trial. The study suggests individualizing care based on patient comfort and needs.
Researchers found that tumor suppressor p53 limits the growth of cells with incorrect numbers of chromosomes and prevents their progression toward cancer. Cells lacking p53 become aneuploid after induced missegregation, indicating that the p53 pathway normally serves to limit the propagation of cells with odd numbers of chromosomes.
Researchers at Florida Institute of Technology are awarded a four-year, $1.024 million NIH grant to continue their studies on cell growth regulation and its implications for human health. The funding will support the development of novel inhibitors that could be used to combat antibiotic-resistant bacterial diseases and treat cancer.
Researchers found that increasing G6PD levels can prevent negative effects of high sugar on beta cells, which produce insulin. This discovery may lead to targeted treatments for diabetes.
Researchers have discovered a new model of fungal growth, known as the 'apical recycling model', which sheds light on how fungi cells shape and grow. This breakthrough has the potential to inform the development of new strategies for preventing and treating fungal diseases in plants and animals.
Scientists develop a laboratory chip with nanoscopic features that enables heart cells to grow and function like natural heart muscle. The 'nanosense' allows cells to collect instructions from the physical patterns on the chip, guiding their behavior.
Researchers found that a plant steroid controls the balance between two genes in rice, regulating leaf angle and cell growth. The discovery has important implications for understanding how to manipulate crop growth and yield, and could lead to better engineering of crops to feed a growing population.
Johns Hopkins researchers found that a protein called vascular endothelial growth factor (VEGF) is responsible for the cell overgrowth in chronic rhinosinusitis with polyps. This discovery gives scientists a new target for treating this form of the disease, which typically resists current treatments.
A new study by Université de Montréal scientists has developed a simple way to decouple one cellular network from another, allowing researchers to distinguish between different cell functions. This discovery could have applications in cancer research, where blood-thirsty cells can be targeted and their growth slowed.
Two Duke University Medical Center scientists, Tannishtha Reya and Michel Bagnat, have won the National Institutes of Health (NIH) Director's Pioneer Award and New Innovator Award respectively. The awards provide $2.5 million and $1.5 million in funding over five years to pursue their research on stem cell growth and fluid secretion.
Researchers have identified a critical role for protein kinase Erk3 in fetal growth potential and lung maturation, revealing the loss of this function leads to fetal growth restriction and early neonatal lethality. This finding provides new insights into intrauterine growth restriction and its associated risks.
Research suggests that PPAR-γ agonist 15d-PGJ2 inhibits gastric cancer cell growth through a mechanism independent of PPAR-γ. The study's findings support the potential therapeutic role of PPAR-γ agonists in chemoprevention or chemotherapy of gastric malignancies.
Researchers at Burnham Institute for Medical Research discovered that the REDD1 protein is degraded under hypoxic conditions, enabling cells to rapidly restore mTOR signaling. This regulation mechanism plays a crucial role in cellular stress response and may be linked to tumor growth in cancer.
Researchers have identified protein Nox4 as crucial for hemangioma growth and found a potent inhibitor fulvene-5 to substantially inhibit its growth. This discovery suggests targeting Nox4 using fulvene derivatives may attenuate hemangioma growth.
Researchers found that chronic exposure to low doses of BPA impairs the growth and function of adult reproductive cells in mice. This can lead to fertility issues due to impaired ovulation and reduced production of essential sex hormones.
A Purdue University scientist has discovered a key process in cell growth that can lead to the formation of tumors. The research found that an overabundance of the polo-like kinase 1 molecule during cell growth, as well as a shortage of the p53 molecule, will lead to tumor formation.
Research by Dr. Susanne Talcott found that extracts from Texas red wines decreased cancer cell growth in a comparable magnitude as other wines previously studied. The study suggests that moderate consumption of Texas wine may offer similar health benefits to those from other regions.
Researchers have developed a method to prevent pod shattering in oilseed rape, reducing seed loss by up to 70% and improving harvest efficiency. By controlling hormone production, scientists can seal seeds inside pods, addressing a major issue in farming this high-value crop.
Research reveals ILK promotes growth in aggressive ARMS cells, while suppressing ERMS cell growth. Targeting ILK may offer therapeutic strategy for ARMS patients.
Researchers at Iowa State University have discovered a previously unknown genetic pathway regulating plant growth, controlled by brassinosteroids. The HERK1 pathway, induced by BRs, plays a significant role in plant size and growth, with potential to manipulate crop yields for biofuels.
Researchers at UT Southwestern Medical Center found that the protein Thymosin beta-4 initiates migration of heart cells and blood vessel growth after a heart attack, encouraging new growth and repair of damaged heart cells. The molecule affects developmental gene expression as early as 24 hours after systemic injection.
Researchers discovered a key checkpoint in cell growth and development that may allow investigators to benchmark progression of tumor cells or stop them from further development. The mechanism involves the activation of p21-activated kinase 2 (PAK2) in certain tissues but not others, and is controlled by the Erbin/Merlin complex.
Researchers at Duke University have developed an approach using magnetism to manipulate human cells, forming chains that can promote the growth of blood vessels. The iron-containing nanoparticles used by the researchers are suspended within a liquid known as a ferrofluid, allowing them to readily manipulate the chain formation.
A study found that docosahexaenoic acid (DHA) can directly suppress arachidonic acid-induced proliferation of colon carcinoma cells, while also reducing viability. DHA supplementation may be a powerful tool to counteract AA- and PGE2-promoted colon cancer cell growth.
A study by Berman et al. reveals that mitochondrial size and shape are regulated by fusion, fission, growth, and degradation processes. The researchers found that a protein called Bcl-xL manages the number, size, and energy-producing capacity of mitochondria.
Researchers at LSU Health Sciences Center have discovered a protein that can interrupt normal cellular proliferation in pancreatic cancer cells. This breakthrough may lead to new treatments for type 1 and 2 diabetes by controlling the growth of islet cells.
Plant cells use microscopic channels called plasmodesmata to communicate and transport nutrients; the GAT1 gene encodes an enzyme that acts as an antioxidant, relieving cellular stress and maintaining flow through these channels. Turning on this gene helps plants prevent excessive callose accumulation and keeps channels open.
The study found that PPAR-gamma activation inhibits pancreatic carcinoma growth by suppressing tumor angiogenesis. In a xenograft model, Rosiglitazone reduced microvascular density and VEGF expression, leading to significant tumor growth inhibition.
Scientists have discovered a chemical that prevents stem cells from turning into other cell types, allowing researchers to grow larger stocks of these cells. This breakthrough has huge potential for treating diseases and injuries without current cures.
Researchers developed intelligent materials that stimulate cell growth and development, eliminating pharmaceutical side-effects. The technology has the potential to revolutionize orthopedic, dental, and cardiovascular prostheses.
Scientists at Johns Hopkins University have found that a protein called Gadd45b is involved in changing epigenetic marks in brain cells, leading to the birth of new neurons and long-term changes in memory. This discovery may help understand how daily life experiences trigger long-lasting memories.
Researchers have identified a single gene, G9a, controlling cell flexibility in embryos and potential for medical cell replacement therapy. This discovery sheds light on the process of cell differentiation and could pave the way for new approaches to reprogram cells in a controlled manner.
Researchers at Columbia University Medical Center discovered a chemical that counters the negative impact of leptin on drug-eluting stents used in diabetic patients. This finding could lead to improved outcomes for diabetics who receive stents.
Researchers at the Rong Li Lab discovered that yeast cells can adapt to disruptions in cell division machinery by increasing their chromosome number and modifying gene expression patterns. This ability may contribute to cancer cell evasiveness and could be used to predict evolutionary paths and outcomes.
Researchers at MIT have discovered that adult brain neurons can remodel their connections, challenging long-held assumptions about the brain's ability to change. This breakthrough could lead to a better understanding of how to promote growth in cells and regions normally unable to repair themselves.
Researchers found that wounded plants produce jasmonates, which inhibit cell division and stunt plant growth. This discovery opens the possibility of improving crop growth through the manipulation of the jasmonate signal pathway.
Researchers describe how cells recycle protein waste to prevent diseases such as Alzheimer's, cystic fibrosis, and developmental disorders. Cells use enzymes and specialized complexes, known as ESCRTs, to break down and dispose of damaged proteins.
Researchers have discovered that only two genes are necessary for converting annuals into perennials, allowing plants to store energy in specialized cells and continue growing for a long time. This breakthrough has significant implications for agriculture and the evolution of plant life strategies.
Research reveals NOD2's importance in regulating colonic epithelial cell growth and survival, highlighting its role in maintaining the integrity of the intestinal epithelial cell barrier. This function is crucial for protection against pathogenic and opportunistic bacterial infections.
Researchers at Baylor College of Medicine found a solution to the high cost of commercial media for 3D cell cultures using chicken egg whites. The process enables normal and cancer cells to be grown in three dimensions, allowing scientists to study cell signaling and tumor microenvironments.
Scientists at Johns Hopkins University School of Medicine have identified over 100 human protein fragments that can slow or stop the growth of cells making up new blood vessels. These compounds, known as antiangiogenesis peptides, could lead to treatments for diseases such as cancer, macular degeneration, and rheumatoid arthritis.
Reinnervate has developed a polystyrene foam scaffold to grow cells in 3D, revolutionizing drug testing and saving companies money. The company is now poised for commercial manufacture and global sales after securing significant funding.
Researchers have identified a critical protein called connexin 43 that is essential for the growth of new blood vessels supporting the development of embryos. Without this protein, embryo implantation may fail, with important implications for early pregnancy loss and female infertility.
Researchers at Duke University have synthesized largazole, a marine algae extract with potential as an anti-cancer agent. The team's efficient synthetic route enables the production of gram-sized quantities, paving the way for further study and potential treatment of various cancers.
Researchers discovered medulloblastomas arise from granule cells and only if they are fully committed. They also found protein Olig2 influences cancer cell formation and multiplication. This knowledge could lead to targeted therapies for childhood brain tumors.
A new study reveals that p53 regulates cells by inhibiting the mTOR pathway, which regulates cell growth. The discovery of Sestrin1 and Sestrin2 as key players in this process may lead to novel cancer preventives and therapeutics.
A study by Carnegie Institution researchers identified key links in the steroid signaling chain using proteomics. Key kinases called BSKs were found to respond to brassinosteroids, filling a major gap in understanding plant hormone regulation.
Scientists at Dana-Farber Cancer Institute discovered that blocking p110beta molecule inhibits prostate tumor growth, suggesting it as a potential target for novel cancer therapies. The study, published in Nature, reveals p110beta's role in driving runaway cell growth when PTEN function is impaired.
Researchers at the University of Illinois have identified a new family of agents that inhibit the growth of estrogen-dependent breast cancer cells. These compounds specifically target the binding of estrogen-receptor complex to regulatory regions of genes, effectively retarding protein production and cell proliferation.
Scientists gather to present research on using mechanics to study and explain biology, highlighting the role of faint pushes and pulls in cellular signaling. The symposium aims to develop fundamental math and mechanics to understand biological processes like embryo development and growth.
A new study identifies CUL7 E3 ubiquitin ligase as a key regulator of protein degradation linked to cellular senescence. The researchers found that the enzyme targets insulin receptor substrate 1 (IRS-1) for degradation, leading to oncogene-induced senescence.
Human cytomegalovirus (HCMV) uses a viral protein to modify tumor-suppressing proteins in human cells, evading cellular control and leading to uncontrolled cell growth. This discovery provides new insights into how viruses cause cancer and could lead to potential treatments.